New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
about
The proximal signaling network of the BCR-ABL1 oncogene shows a modular organizationNovel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic miceDrug targets for cell cycle dysregulators in leukemogenesis: in silico docking studiesGenome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaGenome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaHealth-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemiaCombinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.High-risk childhood acute lymphoblastic leukemiaLong-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.The role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemiaPediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.Liposomal Formulations in Clinical Use: An Updated Review.Leukaemogenesis: more than mutant genesGenetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.6-Thioguanine and S⁶-methylthioguanine are mutagenic in human cellsSulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cellsSuppression of leukemia development caused by PTEN loss.Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemiaBiology, risk stratification, and therapy of pediatric acute leukemias: an update.A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia.Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemiaIdentification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia.Germline genetic variation and treatment response on CCG-1891.Treatment of pediatric acute lymphoblastic leukemia.Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents.Challenging issues in pediatric oncologyMethylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination.Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis.Cytogenetic effect of 5-azacytidine in patients with hematological malignancies.Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952.Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent.MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemiaEffects of 6-thioguanine and S6-methylthioguanine on transcription in vitro and in human cells.BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.Advances in paediatric cancer treatmentNoncoding RNAs and Cancer.From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
P2860
Q24294830-04AF11E6-F2A5-4DEB-A9ED-F10138EAA79DQ27303144-8C9BEAC2-05E0-4F64-9425-DFD26689F3B9Q28538744-95A70F26-6FC6-42E9-B533-8D02FBBEC05CQ28943308-80F43419-3336-4F7F-B10E-BFC075609A10Q28943431-8F972AB4-C019-490B-905A-3B91B78F375BQ30851697-94DC3D77-6B18-4F57-BA01-7E700175F3EBQ33320806-EF4641C6-6579-4D33-8FDE-2A8DC484421AQ33622837-2E79AD2D-341A-4CC0-97B1-9343C41EED54Q33645862-6D56989F-C012-42BD-9DAA-78C3D243551EQ33680280-6D0B532E-3B94-4B81-BF87-BCAAB42F7499Q33737761-CF4A4DB5-B57E-4FAA-925C-82DF11257B4DQ33828575-EE392661-ABBC-4BF1-A1B5-CBB3C9EF6173Q33850427-E32C5740-C26A-4C09-95B1-FE8287DD54AAQ34275371-F3536C8A-4803-4CD2-B27C-276077643FE2Q34400003-6C8924FE-7C5A-45EE-9CF3-7EDB8B179329Q34440523-58FEAB22-FCC2-403E-8F7B-D0767C0F7C7BQ34516308-9FDFCF66-9944-4432-9B53-BD607DBDF970Q34533833-E6882B9B-F193-4902-8E5F-57BF2B4D96EFQ34645214-B5FF1635-5737-45BC-BCB8-7F9264B24D1FQ34764504-374132EE-5294-4E68-B748-C997046804BAQ34989475-87CE9BA1-F38E-454F-833F-EB93F8414E4AQ35040230-D2E11748-097B-4CCE-8102-A1DAD2706568Q35146292-5C244E95-9D90-43F4-B1DF-432B34786217Q35162503-0E0743BF-E383-48C0-9B16-79F9A3F29D80Q35190653-2F634AD6-ABC5-4082-AA2A-C4BA09E20634Q35196702-F90E3F90-E3A8-4B08-804F-070964109593Q35210664-3EFAC06E-8134-432C-8CFF-04429F795C5DQ35602419-AFD33425-4627-46E8-8D77-DC07AD341F94Q35638478-357B8788-ADE4-4167-A7F6-09C166700988Q35758507-97409801-611A-4FB4-AAD7-F813CAD4B551Q36153606-71BFF357-7FC6-4EFB-952F-2675F7FC612CQ36209626-57BA8EC1-5A61-4FC5-B7A0-581500B30864Q36225973-77891BD8-C2BD-45A4-B261-35E1E7845BB2Q36288982-4442D32B-A442-4B9F-9487-F3C0D7586B35Q36436001-1EFB11BB-77A8-4A33-9DF7-928344A277B1Q36445905-B2FBC372-1D96-4786-98E3-E81F515FE8D1Q36508630-7DBECAE4-8243-437E-B462-4C045276F658Q36571216-5C94C68E-1BAE-4783-B7A1-A3806EBA6B9EQ36920786-30830A84-FD99-4E6D-86DD-AA733E548871Q36926841-5FFAA554-8ED2-439C-AC48-49964D24D728
P2860
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@ast
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@en
type
label
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@ast
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@en
prefLabel
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@ast
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@en
P356
P1476
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
@en
P2093
P2888
P304
P356
10.1038/NRD2240
P577
2007-02-01T00:00:00Z
P6179
1026177261